SCHEMBL855748

SCHEMBL855748

Cc1ncnc(Cl)c1CCc1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.43
NR2F2 P24468 1/20 0.43
KMT2A Q03164 1/20 0.43
ENPP1 P22413 1/20 0.42
LMNA P02545 2/20 0.39
ALDH1A1 P00352 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
PIN1 Q13526 1/20 0.36
GALR3 O60755 1/20 0.36
KCNH2 Q12809 1/20 0.36
TLR8 Q9NR97 1/20 0.36
TLR7 Q9NYK1 1/20 0.36
METAP1 P53582 1/20 0.35
PDE4A P27815 1/20 0.35
PDE4B Q07343 1/20 0.35
PDE4C Q08493 1/20 0.35
PDE4D Q08499 1/20 0.35
KDM4E B2RXH2 1/20 0.35
HPGD P15428 1/20 0.35
P2RX3 P56373 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL856520 0.84 ALDH1A1 (0.51) MEN1NR2F2KMT2AENPP1LMNA
SCHEMBL4767677 0.82 ALDH1A1 (0.46) MEN1NR2F2KMT2ALMNAALDH1A1
SCHEMBL858008 0.82 EGFR (0.43) ENPP1SMN1; SMN2KDM4E
SCHEMBL857518 0.76 ALDH1A1 (0.37) ENPP1LMNAALDH1A1SMN1; SMN2GALR3
SCHEMBL21919675 0.74 HRH1 (0.38) LMNAALDH1A1SMN1; SMN2GALR3
SCHEMBL1748938 0.74 ALDH1A1 (0.59) MEN1NR2F2KMT2ALMNAALDH1A1
SCHEMBL857333 0.72 ENPP1 (0.45) ENPP1LMNAALDH1A1SMN1; SMN2KDM4E
SCHEMBL857948 0.72 ENPP1 (0.49) MEN1KMT2AENPP1LMNAALDH1A1
SCHEMBL855372 0.71 ALDH1A1 (0.39) MEN1NR2F2KMT2AENPP1LMNA
SCHEMBL857595 0.71 ALDH1A1 (0.51) MEN1KMT2AENPP1LMNAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2640366-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE Exelixis, Inc. (US) 2013-09-25 EP disclosed
WO-2012068096-A2 BENZOXAZEPINES AS INHIBITORS OF PI3K/MTOR AND METHODS OF THEIR USE AND MANUFACTURE EXELIXIS, INC. (US) 2012-05-24 WO disclosed
EP-2432779-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES Exelixis, Inc. (US) 2012-03-28 EP disclosed
WO-2010135524-A1 BENZOXAZEPINES BASED P13K/MT0R INHIBITORS AGAINST PROLIFERATIVE DISEASES EXELIXIS, INC. (US) 2010-11-25 WO disclosed